| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
XBiotech Inc. (“Company”) and Jan-Paul Simard (“Executive”) (collectively the “Parties”) hereby enter into this Executive Employment Agreement (the “Agreement”) on this 26th day of October, 2026 (the “Effective Date”). In consideration o... |
| 09 Dec 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
XBiotech, Inc. (“XBiotech” or the “Company”) announces that John Simard notified members of the Board of Directors beginning on December 5, 2025 of his intent to retire from his role as President and Chief Executive Officer of the Compan... |
| 03 Oct 2025 |
8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
XBiotech, Inc. (“Company”) and John Simard (“Executive”) (collectively the “Parties”) hereby enter into this Executive Employment Agreement (the “Agreement”) on this 1st day of October, 2025 (the “Effective Date”). In consideration of th... |
| 02 Sep 2025 |
8-K: Submission of Matters to a Vote of Security Holders
The annual meeting of the stockholders of XBiotech Inc. (the “Company”) was held on August 29, 2025. The matters that were voted upon at the meeting, and the number of votes cast for and against, as well as the number of abstentions and ... |
| 24 Jun 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
XBiotech Inc. (“XBiotech” or the “Company”) announces the June 24, 2025 appointments of Dr. Thomas Kündig and Craig Rademaker to the Company’s Board of Directors. Dr. Kündig has further been appointed to serve on the Compensation Committ... |
| 07 Apr 2025 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
As previously reported on the Current Report on Form 8-K filed by the XBiotech Inc. (the “Company”) on April 1, 2025, W. Thorpe McKenzie retired from the Company’s Board of Directors effective March 27, 2025. Independent director Jan-Pau... |
| 01 Apr 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On March 27, 2025, W. Thorpe McKenzie informed the Board of Directors (the “Board”) of XBiotech Inc. (the “Company”) via letter of his decision to retire from the Board, effective immediately. Mr. McKenzie joined the Board in 2009 and se... |
| 31 Dec 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
XBiotech Inc. (the Company) announces the December 24, 2024 appointment of Tak W. Mak, Ph.D. to the Company’s Board of Directors. Pursuant to Section 14.4 of the Company’s Articles, the Board has appointed Dr. Mak to fill the existing va... |
| 20 Jun 2024 |
8-K: Submission of Matters to a Vote of Security Holders
The annual meeting of the stockholders of XBiotech Inc. (the “Company”) was held on June 20, 2024. The matters that were voted upon at the meeting, and the number of votes cast for and against, as well as the number of abstentions and br... |
| 04 Jan 2024 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
This CONVERTIBLE LOAN AGREEMENT (“Agreement”) is made as of January 3, 2024 (the “Effective Date”) by and among XBiotech Inc., a British Columbia corporation (the “Company”), and John Simard (“Lender”). |
| 23 Jun 2023 |
8-K: Submission of Matters to a Vote of Security Holders
The annual meeting of the stockholders of XBiotech Inc. (the “Company”) was held on June 23, 2023. The matters that were voted upon at the meeting, and the number of votes cast for and against, as well as the number of abstentions and br... |
| 15 Feb 2023 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 29 Jun 2022 |
8-K: Submission of Matters to a Vote of Security Holders
The annual meeting of the stockholders of XBiotech Inc. (the “Company”) was held on June 22, 2022. The matters that were voted upon at the meeting, and the number of votes cast for and against, as well as the number of abstentions and br... |
| 13 May 2022 |
8-K: Changes in Registrant's Certifying Accountant
We have read Item 4.01 of Form 8-K dated May 13, 2022, of Xbiotech, Inc. and are in agreement with the statements contained in the last sentence of paragraph 1 and in paragraphs 2 and 3 on page 2 therein. We have no basis to agree or dis... |
| 02 Feb 2022 |
8-K: Entry into a Material Definitive Agreement
XBiotech Manufacturing Antibody Drug for Janssen Research & Development, LLC (Janssen), One of the Janssen Pharmaceutical Companies of Johnson & Johnson |
| 06 Jul 2021 |
8-K: Other Events
AUSTIN, Texas, July 06, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc.’s (NASDAQ: XBIT) (“XBiotech”) Board of Directors has declared an extraordinary cash dividend of approximately $2.50 per share, or up to an aggregate of $75 million, to holder... |
| 29 Jun 2020 |
8-K: Submission of Matters to a Vote of Security Holders
The annual meeting of the stockholders of XBiotech Inc. (the “Company”) was held on June 26, 2020. The matters that were voted upon at the meeting, and the number of votes cast for and against, as well as the number of abstentions and br... |
| 30 Dec 2019 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
[*****] Text omitted for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. |
| 09 Dec 2019 |
8-K: Entry into a Material Definitive Agreement; Other Events
XBiotech will continue its True Human anti IL-1⍺ antibody discovery program outside of dermatology and use its manufacturing technology to produce clinical supplies of bermekimab for Janssen |
| 16 Jul 2019 |
8-K: Departure/Election of Directors or Officers; Compensation; Other Events
This Agreement (this “Agreement”), dated as of the 10 day of July, 2019, is between Peter Libby, M.D., an individual having a residence at 109 Larch Road Cambridge MA 02138 (the “Board Director”), and XBiotech Inc., a British Columbia co... |
Loading...